NCT04524520View on ClinicalTrials.gov

COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery

CompletedOBSERVATIONAL
Enrollment

194

Participants

Timeline

Start Date

May 5, 2020

Primary Completion Date

May 8, 2022

Study Completion Date

June 8, 2022

Conditions
Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients
Trial Locations (1)

Unknown

Dr Luke Hodgson, Worthing

All Listed Sponsors
lead

Western Sussex Hospitals NHS Trust

OTHER

NCT04524520 - COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery | Biotech Hunter | Biotech Hunter